
==== Front
J Transl Med
J Transl Med
Journal of Translational Medicine
1479-5876
BioMed Central London

39313824
5665
10.1186/s12967-024-05665-y
Research
The Chinese visceral adiposity index: a novel indicator more closely related to cardiovascular disease than other abdominal obesity indices among postmenopausal women
Liu Li 1
Peng Jie 2
Zang Dejin 1
Zhang Yerui 1
Wu Zhenguo 1
Song Chunfei 1
Chen Sha 1
Guo Dachuan 1
Lu Fanghong 3
Zheng Tengfei ztf2009@126.com

1
http://orcid.org/0000-0002-8593-2338
Yang Jianmin yangjianminsdu@163.com

1
1 grid.452402.5 0000 0004 1808 3430 National Key Laboratory for Innovation and Transformation of Luobing Theory, The Key Laboratory of Cardiovascular Remodeling and Function Research, Department of Cardiology, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, Qilu Hospital of Shandong University, No 107, Wenhuaxi Road, Jinan, Shandong China
2 https://ror.org/056ef9489 grid.452402.5 0000 0004 1808 3430 Key Laboratory of Cardiovascular Proteomics of Shandong Province, Department of Geriatric Medicine, Qilu Hospital of Shandong University, Jinan, China
3 https://ror.org/05jb9pq57 grid.410587.f Cardio-Cerebrovascular Control and Research Center, Shandong Academy of Medical Sciences, Jinan, China
23 9 2024
23 9 2024
2024
22 8556 9 2023
4 9 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
Background

Several abdominal obesity indices including waist circumference (WC), waist–hip ratio (WHR), visceral adiposity index (VAI), lipid accumulation product (LAP), and Chinese visceral adiposity index (CVAI) were considered effective and useful predictive markers for cardiovascular disease (CVD) in general populations or diabetic populations. However, studies investigating the associations between these indices among postmenopausal women are limited. Our study aimed to investigate the associations of the five indices with incident CVD and compare the predictive performance of CVAI with other abdominal obesity indices among postmenopausal women.

Methods

A total of 1252 postmenopausal women without CVD at baseline were analyzed in our investigation based on a 10-year follow-up prospective cohort study. Link of each abdominal obesity index with CVD were assessed by the Cox regression analysis and the Kaplan–Meier curve. The receiver operating characteristic (ROC) curves were drawn to compare the predictive ability for CVD.

Results

During the median follow-up of 120.53 months, 121 participants newly developed CVD. Compared to quartile 1 of LAP and CVAI, quartile 4 had increased risk to develop CVD after fully adjusted among postmenopausal women. When WC, VAI and CVAI considered as continuous variables, significant increased hazard ratios (HRs) for developing CVD were observed. The areas under the curve (AUC) of CVAI (0.632) was greatly higher than other indices (WC: 0.580, WHR: 0.538, LAP: 0.573, VAI: 0.540 respectively).

Conclusions

This study suggested that the abdominal obesity indices were associated with the risk of CVD excluded WHR and highlighted that CVAI might be the most valuable abdominal obesity indicator for identifying the high risk of CVD in Chinese postmenopausal women.

Supplementary Information

The online version contains supplementary material available at 10.1186/s12967-024-05665-y.

Keywords

Abdominal obesity indices
Cardiovascular disease
Chinese postmenopausal women
Chinese visceral adiposity index
the National Key Research and Development Program of ChinaNo.2021YFF0501403 Yang Jianmin http://dx.doi.org/10.13039/100022963 Key Research and Development Program of Zhejiang Province No. 2021SFGC0503 Yang Jianmin issue-copyright-statement© BioMed Central Ltd., part of Springer Nature 2024
==== Body
pmcBackground

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in women worldwide, with a proportion of 35% of all death causes [1]. Since 1990, China showed a steady increase in the prevalence of CVD among women [2]. However, women cardiovascular health and cardiovascular risk were underemphasized during the past decade [3, 4]. As a result, it is essential to explore effective influencing factors for CVD in order to better predict cardiovascular disease and provide valuable strategies for women. Previous study evidenced that the fatality rate of CVD had increased largely among women at midlife (40–65 years), the same time as menopause [5]. Menopause, with the reduction and even disappearing of estrogen levels, is considered a turning point for women’s cardiometabolic change [5]. Women after menopause were found to have a notably higher probability to develop CVD, identifying that menopausal transition relates to increased cardiovascular risk [6] and preventive strategies required [7].

Former studies indicated that close relationship may exist between the menopause transition and the occurrence of obesity among women [8, 9]. Obesity has been considered as an important cardiovascular risk factor by accumulative evidence. Although body mass index (BMI) is frequently utilized to classify overweight or obesity, it cannot neither distinguish the lean mass and total fat mass nor capture the distribution of body fat [10]. Furthermore, menopause transition lead to an increased abdominal fat deposition compared to peripheral fat deposition [11, 12], and accumulative evidence demonstrated that adipose tissue distribution rather than overall adiposity is more critical in determining CVD risk [13].

Radiological imaging techniques can accurately assess abdominal adiposity, however, the expensive cost, time consuming and radiation hazards restrict its application in large-scale clinical investigation [14]. Thus, simple, effective, non-invasive, and easily accessible markers closely associated with abdominal fat required to be established. Electrocardiogram (ECG) and coronary angiography are important methods to diagnose coronary heart disease (CHD). Nevertheless, ECG and coronary angiography may be normal at baseline in healthy population. Screening high risk population for CVD is very useful for early intervention and treatment. Considering the low detection rate of ECG at baseline and the high cost and complex operation of coronary angiography, we aimed to discover a surrogate marker for predicting CVD. As is known to all, waist circumference (WC) is considered as a traditional abdominal fat index. Recently, several newly established indicators were found to have independently predictive values for CVD incidence in general population, including waist–hip ratio (WHR), lipid accumulation product (LAP), visceral adiposity index (VAI) and Chinese visceral adiposity index (CVAI) [15, 16]. However, there is still unclear about the longitudinal association of these indices with CVD risk in postmenopausal women. Thus, it is necessary to examine further which abdominal obesity index is the optimal predictor of CVD in postmenopausal women. The present study aimed to investigate the association between the abdominal fat indicators with CVD incidence and compared their risk prediction performances in a prospective cohort study.

Methods

Study population

The present study launched during the period from 2005 to 2006, enrolled participants aged 35–70 from 12 communities in Eastern China and conducted a 10-year follow-up. To obtain perfectly representative sample of the general Eastern China populations against area variations interference, participants were required to have resided in the specific community for a minimum of 5 years, selected by a random, multi-stage and cluster sampling.

From 2005 to 2006, a total of 2112 postmenopausal women participants were included in our research. After excluding participants with CVD history at baseline (n = 268), with missing data of the baseline information (n = 139), with abnormal menopausal age (< 45 years or > 55 years, n = 279), there were 1426 postmenopausal women participants available included in our investigation.

With the rapid economic development and unprecedented urbanization, the migration flow in China over the past two decades has rapidly increased [17]. After a median follow-up period of 120.53 months, 174 postmenopausal women were lost to follow-up with a shedding rate of 12.2%. Totally, 1252 participants eventually took part in the present analysis (Fig. 1).Fig. 1 Flow diagram of patient selection. CVD cardiovascular disease

The study was approved by the Ethics Review committee of the Shandong Academy of Medical Sciences (Approval Number: 202111120194) and conducted in conformity with the Declarations of Helsinki. Written informed consent were provided from all participants.

Baseline survey and definitions

Participants were asked to carry out the standardized questionnaire investigations on their baseline information face to face established by professional and well-trained staffs, contained with socio-demographic information (age, sex, menopausal information, number of children and education level), life styles (smoking status, alcohol drinking status, physical activity and energy intake percentage from fat and carbohydrate), individual histories of diseases (diabetic mellitus, hypertension and CVD) and taking medication (antihypertensive, antidiabetic and antilipemic drugs). The menopausal information involved the menarcheal age, the menstrual cycles, having gone through menopause or not and age at menopause. The number of children was categorized into 5 groups, including 0, 1, 2, 3, and ≥ 4. Education level was divided into three categories, inclusive of pre-secondary school, secondary school and post-secondary school. Smoking and alcohol drinking status were both defined as never, former or current. Physical activity was self-reported, based on the International Physical Activity Questionnaire (IPAQ) in 1998, the most widely used instrument applicable across countries for monitoring and assessing population physical activity level [18]. Low physical activity was defined as < 600 metabolic equivalent task (MET) × minutes per week or < 150 min per week of moderate intensive physical activity. Energy intake percentage from fat and carbohydrate were divided into three according to the tertiles. The diagnostic criteria for diabetic mellitus (DM) was fasting plasma glucose > 6.9 mmol/L, a self-reported history of DM or the utilization of antidiabetic drugs [19]. Similarly, hypertension was defined as systolic blood pressure (SBP) > 140 mmHg or diastolic blood pressure (DBP) > 90 mmHg, having been diagnosed with hypertension or the use of antihypertensive drugs [20].

Clinical laboratory results were obtained by experienced physicians collecting participants’ venous blood samples of the anterior elbow after an overnight fast for a minimum of 8 h and next testing. Professional experimental staffs in the laboratory were in charge of measuring the biochemical indexes using standardized autoanalyzers, including total cholesterol (TC), triglyceride (TG), fasting plasma glucose (FPG), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C).

The regularly calibrated sphygmomanometer was applied to estimate participants’ blood pressure by professional physicians complying with standard steps repeatedly and the mean of the three measurements was computed. In order to get an accurate blood pressure reading, participants should be required to empty their bladders, with no food or drink for at least 30 min and sit comfortably for a minimum of 5 min before measuring, put both feet flat on the ground and rest their arms on the table with the cuff at chest height against bare skin without talking during the measurement.

Anthropometric indices such as height, weight, waist circumference and hip circumference were measured twice by well-trained clinicians following standardized protocols and then the averages calculated were applied for further analysis. When measuring, the participants were required to stand straight without shoes, heels together, look straight ahead and take only minimal clothes. The waist circumference was measured at the level of the umbilicus around the abdomen using tapes. The WHR was calculated by dividing WC (cm) by hip circumference (cm). As for the values of other abdominal obesity indices, the formulas for estimation were shown by sex as follows according to previous published researches [21].

Males:CVAI=-267.93+0.68×agey+0.03×BMIkg/m2+4.00×WCcm+22.00×Log10TGmmol/L-16.32×HDL-Cmmol/L;

VAI=WCcmWCcm39.68+1.88×BMlkg/m239.68+1.88×BMlkg/m2×1.31/HDL-Cmmol/L×TGmmol/L/1.03;

LAP=WCcm-65×TGmmol/L;

Females:CVAI=-187.32+1.71×agey+4.23×BMIkg/m2+1.12×WCcm+39.76×Log10TGmmol/L-11.66×HDL-Cmmol/L;

VAI=WCcmWCcm36.58+1.89×BMIkg/m236.58+1.89×BMIkg/m2×1.52/HDL-Cmmol/L×TGmmol/L/0.81;

LAP=WCcm-58×TGmmol/L.

Follow-up for outcomes

After 10-year follow-up, we collected the information of outcomes, including CVD, CHD and stroke. CVD was defined as CHD (myocardial infarction, angina pectorals or angiography-proven CHD) or stroke (ischemic, hemorrhagic or unspecified stroke) according to the hospital record documents or the imaging evidence.

Statistical analysis

All reported p-values in the tables and figures were two-sided and p value < 0.05 was considered statistically significant. All statistical analyses and figures were completed with R software version 4.2.0 (R Foundation for Statistical Computing). Baseline characteristics of eligible study participants were displayed according to the presence of outcomes. Continuous variables distributed normally were summarized as means and standard deviations (SD) while non-normal distribution data were expressed as medians and interquartile ranges. As for categorical variables, frequencies and percentages were calculated. To compare the differences at baseline with and without CVD, the t-test and the Wilcoxon rank-sum test were applied for analyzing continuous data while the Pearson chi-square for categorical data. The five abdominal obesity indices at baseline were grouped by the quartiles, named quartile 1 (Q1), quartile 2 (Q2), quartile 3 (Q3) and quartile 4 (Q4). The cumulative rates of CVD of each abdominal obesity indices were compared among groups categorized by the quartiles using the Kaplan–Meier curves and the log-rank test. Hazard ratios (HRs) and 95% confidence intervals (CIs) of CVD were obtained using univariate and multivariate Cox regression to assess the associations between the incident CVD and the five abdominal obesity indices, with Q1 as reference. HRs (95% CIs) for per Unit and per SD increase of the five abdominal obesity indices were separately calculated. We performed the cox.zph() function with R software to confirm the proportional hazards assumption. The results show that there is no significant deviation from the proportional hazards assumption for all independent variates with all p-values > 0.05, and an associated global significant test gives a p value (> 0.05) which means good fit of the proportional hazard Cox regression models. To explore the independent predictive performance of five abdominal obesity indices, four Cox regression models based on the cardiovascular risk factors were established. Model 1 was only adjusted by age. Model 2 was adjusted by age, education, smoking, drinking and physical activity. Model 3 was adjusted by age, education, number of children, smoking, drinking, physical activity, TC, LDL-C, utilization of antihypertensive drugs, antidiabetic drugs and antilipemic drugs, energy intake percentage of fat and carbohydrates, and diagnosed with DM and hypertension at baseline. Considering that the present study focused on postmenopausal women, Model 4 was adjusted for variables in Model 3 plus age at menopause. Subgroup analyses stratified by age at menopause (< 48 years, 48–50 years or > 50 years), diagnosed with DM and hypertension at baseline (yes or no) were performed to evaluate the robustness of the results, with p for interaction calculated. Additionally, to compare the predictive performance of the five abdominal obesity indices for CVD, we drew the receiver operating characteristic (ROC) curve and calculated the area under ROC (AUC). P for comparison was used to confirm the differences of predictive performance statistically significantly. To further evaluate the improvement in discrimination and risk reclassification for CVD, with the addition of the five abdominal obesity indices, C-statistic, the net reclassification index (NRI) and the integrated discrimination improvement (IDI) were performed. Moreover, given that CVD was the composition of CHD and stroke in our study, sensitive analyses regarding the predictive value of the five indices for CHD and stroke, and the associations of CVAI with the incident CHD and stroke among postmenopausal women were also conducted by the AUC values, the ROC curves and the Cox regression analyses.

Results

Baseline characteristics

The subject characteristics of the participants divided by the presence of incident CVD are shown in Table 1. During the median follow-up of 120.53 months, 121 participants (9.66%) newly developed CVD. The mean age and mean age at menopause of the 1252 participants included were 57.79 years and 49.45 years respectively. Compared to participants without CVD, participants newly developing CVD during follow-up tend to be older, current smokers, with higher values of SBP, DBP and BMI, with utilization of antihypertensive drugs and antilipemic drugs and with hypertension at baseline (all p < 0.05). Statistically significant differences of the energy intake from carbohydrate were observed in the two groups stratified by the presence of CVD (p = 0.046). Additionally, participants with CVD seemed to be with increased levels of the four abdominal obesity indices, including WC, LAP and CVAI (all p < 0.05) (Table 1).Table 1 Baseline characteristics of the study population by the CVD status at follow-up

Variables	Total (n = 1252)	Non-CVD (n = 1131)	Incident CVD (n = 121)	P-value	
Age (years)	57.79 ± 5.70	57.65 ± 5.68	59.10 ± 5.72	0.008	
Age at menopause (years)	49.45 ± 2.35	49.42 ± 2.34	49.74 ± 2.38	0.157	
SBP (mmHg)	144.78 ± 24.07	143.77 ± 23.71	154.31 ± 25.35	< 0.001	
DBP (mmHg)	85.45 ± 12.99	85.02 ± 13.00	89.51 ± 12.19	< 0.001	
TC (mmol/L)	5.05 ± 0.95	5.04 ± 0.96	5.14 ± 0.89	0.283	
TG (mmol/L)	1.42 (1.06)	1.39 (1.04)	1.51 (1.12)	0.100	
LDL-C (mmol/L)	2.91 ± 0.80	2.89 ± 0.80	3.03 ± 0.76	0.081	
HDL-C (mmol/L)	1.38 ± 0.32	1.38 ± 0.31	1.34 ± 0.35	0.180	
WC (cm)	84.18 ± 9.41	83.93 ± 9.36	86.55 ± 9.62	0.003	
BMI (kg/m2)	24.93 ± 3.59	24.78 ± 3.54	26.38 ± 3.76	< 0.001	
WHR	0.86 ± 0.05	0.86 ± 0.05	0.86 ± 0.05	0.497	
LAP	36.11 (36.66)	35.21 (35.57)	44.10 (47.39)	0.008	
VAI	2.00 (1.68)	1.97 (1.58)	2.06 (2.10)	0.148	
CVAI	101.78 ± 30.84	100.43 ± 30.29	114.42 ± 33.17	< 0.001	
Smoking, n (%)	
 Former	5 (0.4)	5 (0.4)	0 (0)	0.048	
 Current	24 (1.9)	18 (1.6)	6 (5)	
 Never	1223 (97.7)	1108 (98)	115 (95)	
Drinking, n (%)	
 Former	8 (0.6)	6 (0.5)	2 (1.7)	0.227	
 Current	16 (1.3)	15 (1.3)	1 (0.8)	
 Never	1228 (98.1)	1110 (98.1)	118 (97.5)	
Education, n (%)	
 Secondary	777 (62.1)	713 (63)	64 (52.9)	0.058	
 Pre-secondary	430 (34.3)	380 (33.6)	50 (41.3)	
 Post-secondary	45 (3.6)	38 (3.4)	7 (5.8)	
Percent energy intake from fat, n (%)	
 Tertile 1	418 (33.4)	386 (34.1)	32 (26.4)	0.228	
 Tertile 2	417 (33.3)	371 (32.8)	46 (38)	
 Tertile 3	417 (33.3)	374 (33.1)	43 (35.5)	
Percent energy intake from carbohydrate, n (%)	
 Tertile 1	418 (33.4)	366 (32.4)	52 (43.0)	0.046	
 Tertile 2	417 (33.3)	379 (33.5)	38 (31.4)	
 Tertile 3	417 (33.3)	386 (34.1)	31 (25.6)	
Antihypertensive drugs, n (%)	223 (17.8)	184 (16.3)	39 (32.2)	< 0.001	
Antidiabetic drugs, n (%)	49 (3.9)	42 (3.7)	7 (5.8)	0.318	
Antilipemic drugs, n (%)	54 (4.3)	40 (3.5)	14 (11.6)	< 0.001	
Low physical activity, n (%)	183 (14.6)	170 (15)	13 (10.7)	0.225	
Number of children, n (%)	
 0	5 (0.4)	4 (0.4)	1 (0.8)	0.297	
 1	322 (25.7)	299 (26.4)	23 (19)	
 2	537 (42.9)	479 (42.4)	58 (47.9)	
 3	248 (19.8)	222 (19.6)	26 (21.5)	
 ≥ 4	140 (11.2)	127 (11.2)	13 (10.7)	
Hypertension, n (%)	750 (59.9)	657 (58.1)	93 (76.9)	< 0.001	
Diabetic mellitus, n (%)	117 (9.3)	103 (9.1)	14 (11.6)	0.410	
Continuous variables distributed normally were summarized as mean ± SD while non-normal distribution data were expressed as medians and interquartile ranges. Categorical variables were given by frequency and percentage as n(%)

p values in bold are < 0.05

CVD cardiovascular disease, SBP systolic blood pressure, DBP diastolic blood pressure, TC total cholesterol, TG triglyceride, LDL-C low-density lipoprotein-cholesterol, HDL-C high-density lipoprotein-cholesterol, WC waist circumference, BMI body mass index, WHR waist–hip ratio, LAP lipid accumulation product, VAI visceral adiposity index, CVAI Chinese visceral adiposity index, SD standard deviation

Correlations between abdominal obesity indices and CVD incidence among postmenopausal women

The correlations between abdominal obesity indices and CVD incidence were shown in Additional file 1: Table S1 and Table 2 using the Cox regression analyses. Compared to lowest group of LAP and CVAI at baseline, the fully adjusted HRs (95% CIs) for CVD in the highest quartile group were 1.747 (1.013, 3.012) and 1.893 (1.078, 3.323) respectively. In addition, the corresponding HRs (95% CIs) for per SD increase in WC, VAI and CVAI were 1.210 (1.002, 1.460), 1.143 (1.029, 1.269) and 1.407 (1.147, 1.726) respectively. Similarly, significant associations of CVD with WC, VAI and CVAI when estimated as continuous variables. However, no significant correlation between WHR and CVD was found when WHR was estimated as a continuous or a categorical variable (Additional file 1: Table S1 and Table 2).Table 2 Correlations of baseline abdominal obesity indices with incident CVD among postmenopausal women after fully adjusted using Model 4

HR (95% CI)	Indices	
WC	WHR	LAP	VAI	CVAI	
Per unit increase	1.020 (1.000, 1.041)*	1.009 (0.033, 31.233)	1.002 (0.999, 1.005)	1.053 (1.011, 1.096)*	1.011 (1.004, 1.018)**	
Per SD increase	1.210 (1.002, 1.460)*	1.000 (0.831, 1.204)	1.097 (0.947, 1.270)	1.143 (1.029, 1.269)*	1.407 (1.147, 1.726)**	
Quartiles	
 Q1	1.00	1.00	1.00	1.00	1.00	
 Q2	1.072 (0.596, 1.929)	0.678 (0.383, 1.201)	0.804 (0.448, 1.442)	0.760 (0.443, 1.304)	0.663 (0.353, 1.244)	
 Q3	1.350 (0.771, 2.361)	0.993 (0.595, 1.656)	1.053 (0.603, 1.838)	0.821 (0.478, 1.412)	0.881 (0.484, 1.605)	
 Q4	1.673 (0.973, 2.877)	1.182 (0.718, 1.944)	1.747 (1.013, 3.012)*	1.317 (0.787, 2.203)	1.893 (1.078, 3.323)*	
Model 4: adjusted by age, education, number of children, smoking, drinking, physical activity, TC, LDL-C, utilization of antihypertensive drugs, antidiabetic drugs and antilipemic drugs, energy intake percentage of fat and carbohydrates, diagnosed with DM and hypertension at baseline and age at menopause

CVD cardiovascular disease, HR hazard ratio, CI confidence interval, WC waist circumference, WHR waist–hip ratio, LAP lipid accumulation product, VAI visceral adiposity index, CVAI Chinese visceral adiposity index, SD standard deviation, TC total cholesterol, LDL-C low-density lipoprotein-cholesterol, DM diabetic mellitus

*p < 0.05

**p < 0.01

As shown in Fig. 2, the Kaplan–Meier curves and the log-rank test during the follow-up time further confirmed the significantly elevated risk of incident CVD in the highest group of WC, LAP and CVAI among postmenopausal women (Fig. 2).Fig. 2 Kaplan–Meier curves of CVD by abdominal obesity indices quartiles. The cumulative incidence of CVD during follow-up grouped by the abdominal obesity indices quartiles was described using Kaplan–Meier curves, with p value calculated using the log-rank test. The abdominal obesity indices are contained with WC (A), WHR (B), LAP (C), VAI (D) and CVAI (E). CVD cardiovascular disease, WC waist circumference, WHR waist–hip ratio, LAP lipid accumulation product, VAI visceral adiposity index, CVAI Chinese visceral adiposity index

Subgroup analyses

Subgroup analyses stratified by age at menopause, hypertension and DM in Model 4 are demonstrated in Fig. 3. However, we did not find statistically significant differences in the association between the five indices and CVD incidence across the subgroups according to the interaction tests. (all P > 0.05) (Fig. 3).Fig. 3 Correlations of baseline abdominal obesity indices with incident CVD among postmenopausal women in prespecified subgroups. HR are adjusted for age, education, number of children, smoking, drinking, physical activity, TC, LDL-C, utilization of antihypertensive drugs, antidiabetic drugs and antilipemic drugs, energy intake percentage of fat and carbohydrates, and diagnosed with DM, hypertension and age at menopause at baseline. CVD cardiovascular disease, HR hazard ratio, CI confidence interval, WC waist circumference, WHR waist–hip ratio, LAP lipid accumulation product, VAI visceral adiposity index, CVAI Chinese visceral adiposity index, TC total cholesterol, LDL-C low-density lipoprotein-cholesterol, DM diabetic mellitus

Assessment of the predictive performance of abdominal obesity indices for incident CVD

The ROC curves and the AUC values exhibiting the predictive ability of abdominal obesity indices for incident CVD were shown in Fig. 4 and Table 3. CVAI showed superior performance to other four abdominal obesity indices for predicting the CVD incidence. Moreover, with the P for comparison calculated to explore the differences of the AUCs between CVAI and other indices significant or not, CVAI showed the largest AUC estimated significantly different from other AUCs (all p < 0.01). The AUCs (95% CIs) of WC, WHR, LAP, VAI and CVAI were 0.580 (0.526, 0.634), 0.538 (0.481, 0.595), 0.573 (0.519, 0.627), 0.540 (0.484, 0.596) and 0.632 (0.576, 0.688) respectively (Fig. 4 and Table 3).Fig. 4 Receiver operating characteristic curves of CVD by abdominal obesity indices. The predictive performance of abdominal obesity indices for incident CVD was shown based on the receiver operating characteristic curves. The AUCs are as follows: CVAI: 0.632; WC: 0.580; LAP: 0.573; VAI: 0.540; WHR: 0.538. CVD cardiovascular disease, AUC area under the curve, CVAI Chinese visceral adiposity index, WC waist circumference, LAP lipid accumulation product, VAI visceral adiposity index, WHR waist–hip ratio

Table 3 The predictive performance of abdominal obesity indices for incident CVD among postmenopausal women

Indices	C-statistic (95% CI)	P-value	P for comparison	
CVAI	0.632 (0.576, 0.688)	< 0.001	Ref.	
LAP	0.573 (0.519, 0.627)	0.008	< 0.001	
WC	0.580 (0.526, 0.634)	0.004	0.003	
WHR	0.538 (0481, 0.595)	0.148	< 0.001	
VAI	0.540 (0.484, 0.596)	0.168	< 0.001	
p values in bold are < 0.05

CVD cardiovascular disease, CI confidence interval, CVAI Chinese visceral adiposity index, Ref. reference, LAP lipid accumulation product, WC waist circumference, WHR waist–hip ratio, VAI visceral adiposity index

Additional predictive value of abdominal obesity indices in the risk assessment of CVD among postmenopausal women

The additional predictive performance of abdominal obesity indices for CVD among postmenopausal women after adding these indices to the basic risk model 4 established by traditional cardiovascular risk are shown in Table 4. CVAI demonstrated significantly enhanced incremental predictive ability according to the estimation of C-statistics, IDI and NRI and corresponding P values. When CVAI added to the basic model including age, age at menopause, education, number of children, smoking, drinking, physical activity, TC, LDL-C, utilization of antihypertensive drugs, antidiabetic drugs and antilipemic drugs, percentage intake of fat and carbohydrates, and diagnosed with DM and hypertension at baseline, the C-statistics, IDI, continuous NRI and 95% CIs were 0.690 (0.641, 0.739), 0.0125 (0.005, 0.0201) and 0.3277 (0.1426, 0.5128) respectively (all p ≤ 0.001). However, no statistically significant additional predictive values of WHR, LAP and VAI were observed (Table 4).Table 4 The incremental predictive value of the abdominal obesity indices for CVD

Model	C-statistic
D-(95% CI)	P-value	IDI (95% CI)	P-value	NRI (95% CI)	P-value	
Basic model	0.676 (0.630, 0.723)	Ref.	Ref.		Ref.		
+ WC	0.679 (0.631, 0.727)	0.043	0.0043 (2e−04, 0.0084)	0.041	0.1353 (− 0.052, 0.3226)	0.157	
+ WHR	0.676 (0.629, 0.722)	0.810	2e−04 (− 3e−04, 6e−04)	0.482	0.0409 (− 0.1464, 0.2282)	0.669	
+ LAP	0.679 (0.632, 0.725)	0.208	0.0017 (− 7e−04, 0.0041)	0.168	0.0595 (− 0.1236, 0.2427)	0.524	
+ VAI	0.681 (0.635, 0.728)	0.010	0.0118 (− 0.0028, 0.0264)	0.112	0.1155 (− 0.0666, 0.2976)	0.214	
+ CVAI	0.690 (0.641, 0.739)	< 0.001	0.0125 (0.005, 0.0201)	0.001	0.3277 (0.1426, 0.5128)	< 0.001	
p values in bold are < 0.05

CVD cardiovascular disease, CI confidence interval, IDI integrated discrimination improvement, NRI net reclassification improvement, Ref. reference, WC waist circumference, WHR waist–hip ratio, LAP lipid accumulation product, VAI visceral adiposity index, CVAI Chinese visceral adiposity index

Sensitivity analyses for CVAI

As displayed in Additional file 1: Table S2, positive predictive performance of WC, LAP, CVAI for incident CHD were observed among postmenopausal women, among which CVAI had the largest AUC being 0.632 (0.567, 0.698). Moreover, significant differences existed in the comparison between CVAI and LAP. As for predicting the incident stroke, only CVAI showed significant predictive ability with the AUC being 0.613 (0.527, 0.700) (Additional file 1: Table S2).

Additional file 1: Table S3 and Figure S1 confirmed the positive correlations of CVAI with incident CHD but no significant associations with incident stroke, using the Cox regression analyses and the Kaplan–Meier curves. After adjusted in Model 4, the HRs (95% CIs) for the Q4 group of CHD and stroke were 1.985 (1.018, 3.872) and 2.451 (0.894, 6.717) respectively (Additional file 1: Table S3 and Figure S1).

Discussion

In this prospective cohort study of postmenopausal women conducted in China, we observed and compared the predictive power of five abdominal obesity indices for the CVD incidence. Positive association were found between these indices and the risk of future CVD among postmenopausal women excluding WHR. Furthermore, CVAI exhibited the greatest power in predicting CVD incidence comparing with WC, WHR, VAI and LAP. Additionally, when adding the five abdominal obesity indices to the conventional risk model, CVAI exhibited significant additional predictive ability for the incident CVD.

The continuing rise in obesity prevalence to date has posed a major public health challenge globally. According to the Global Burden of Disease Study, the prevalence of obesity has doubled in more than 70 countries [22]. Obesity associated with the risk of numerous chronic diseases, such as diabetic mellitus, cancers and cardiovascular disease and lower life expectancy [23]. However, BMI is imperfect in the evaluation of abdominal body fat accumulation, which can neither distinguish body fat distribution with overall adiposity, nor distinguish fat mass with lean muscle mass [10, 24]. Investigations demonstrated that taking body fat distribution into consideration when measuring may improve the predictive ability of diseases [25]. Abdominal obesity was evidenced to have higher risk to develop CVD than overall obesity [26, 27]. In comparison with subcutaneous adipose tissue, visceral adiposity tissue is evidenced to be metabolically more active and secrete cytokines, adipokines and hormones at a higher speed that biologically associated with chronic diseases by the insulin/insulin-like growth factor (IGF) axis and chronic low-grade inflammation [28]. However, WC, a traditional index related to abdominal obesity, is hard to tell visceral obesity from subcutaneous obesity. Hence, besides WC, we introduced other four indices, WHR, CVAI, VAI, LAP to compare the predictive values for CVD in the present study. Postmenopausal women predispose to obesity and a closer relationship between CVD and postmenopausal women than general populations were found [6], due to the remarkable decrease of estrogen [29]. Previous researches have compared the five abdominal obesity indices and confirmed their close association with the development of CVD only in general populations or diabetic populations [15, 21]. As a result, our study was the first to focus on the five abdominal obesity indices in postmenopausal women and to fill in the gap.

The present study underscored that CVAI showed not only the most outstanding predictive performance for the development of CVD, but also the greatest incremental risk stratification when added to the conventional risk model among women after menopause. Considerable studies have emphasized the important effect of obesity on the cardiovascular risk and CVD. However, focusing on BMI or WC alone is a crude oversimplification of obesity. Additionally, postmenopausal women are prone to the accumulation of visceral adiposity for changes of physiology and life styles. Previous evidence found that higher abdominal fat was related to increased health risk irrespective of the value of BMI [30]. Abdominal fat is a composition of subcutaneous and visceral adipose tissue, among which visceral adiposity tissue showed closer relationship with the incident CVD and had more deleterious effect on cardiometabolic outcomes [31]. Furthermore, excess visceral adiposity tissue (VAT), defined as the amount of adiposity tissue located in the abdominal cavity, was found to increase the cardiometabolic risk and cardiovascular outcomes at any BMI level [30]. High level of plasma triglyceride were regarded as an effective and simple marker for evaluating excess visceral adiposity with a large waistline existing [32, 33]. CVAI incorporates anthropometric indices and lipid profiles including triglyceride and HDL, which is closely associated with visceral adiposity surpassing other traditional anthropometric indices in Chinese population [34]. Additionally, CVAI is the only index that takes age into account compared to other indexes in our study. A large number of previous studies have shown that age is an independent risk factor that promotes the occurrence and development of cardiovascular diseases. Previous study found that senescent cells secreted cytokines, chemokines, growth factors, and reactive oxygen species, so-called senescence-associated secretory phenotype (SASP), leading to the development and progression of cardiovascular diseases [35], which of course may not correspond to biological age, but should be considered in future study. In the previous studies with regard to the comparison of obesity indicators, CVAI showed the largest predictive value not only for cardiovascular risk factors such as DM [34], hypertension [36] and carotid plaque [37] but also for the development of CVD [15], CHD [38] and stroke [39]. Previous studies have focused on CVAI and different cardiovascular events among different populations. For example, CVAI is considered effective for risk stratification of stroke in middle-aged and elderly participants from the China Health and Retirement Longitudinal Study (CHARLS) [40]. Previous cohort studies also evidenced the association of CVAI with CHD and Risk of Carotid Plaque in large Chinese populations [37, 38]. Women who have occurred menopause were faced with increasing risk to develop cardiovascular disease, which made it meaningful to explore the effect of CVAI on cardiovascular disease among postmenopausal women. To our best knowledge, our current study is the first to focus on the association between CVAI and CVD risk among postmenopausal women. Similar with our findings, a study in Southwest China confirmed that CVAI was the strongest predictive indicator for the incident CVD among female subjects compared to other visceral adiposity indices [15]. As a result, the present findings proposed that CVAI could be adopted as a simple and easily available clinical accessing tool to identify postmenopausal women at high risk of CVD development. However, what should be pointed out is that the AUC of CVAI in our analysis was less than 0.70. Considering the complex pathogenesis of cardiovascular disease, it is difficult to discover a single index for risk prediction. In addition, abdominal obesity can only partially explain the onset of cardiovascular disease.

In the present study, no significant correlation between WHR and CVD was found when WHR was estimated as a continuous or a categorical variable. Similar to our results, WHR was found to have no significant association with CVD incidence in women population with DM or without after fully adjusted [41, 42]. One probable explanation could be postmenopausal women tend to have not only higher value of WHR [43], but also other increased cardiovascular risk, such as increased total cholesterol and LDL cholesterol [44], which in case may reflect weak or even no relationship between WHR and CVD incidence.

The subgroup analyses found the significant association between CVAI and the occurrence of CVD among postmenopausal women with age at menopause > 50 years, with the history of hypertension, with or without the history of DM. Post menopausal women tend to accumulate visceral fat. Moreover, cardiovascular risk remarkably increases in women with menopause occurring before age 50, compared with those after 50 [45, 46], which may obscure the effect of CVAI, leading to a higher link between CVAI and CVD among women with menopausal age > 50 years.

Although another study from Rural Chinese Cohort Study data found the excellent predictive ability for stroke of CVAI in general population [39], the sensitive analysis evidenced the association of CVAI with CHD but no significant relationship with stroke. More investigations focusing on postmenopausal women and the risk of stroke development were needed in the future.

However, several limitations should be mentioned in the study. Firstly, because the survey focused on the community population, we did not test the actual value of visceral adiposity by computed tomography (CT), dual-energy x-ray absorptiometry (DXA) or magnetic resonance imaging (MRI), and fat mass index (FMI), VAT were not available. Secondly, our study was conducted in Eastern China, and our findings might not be appropriate for other regions due to the differences of lifestyles and residential environment. Thirdly, despite adjusting for potential risk factors in multivariate analyses, some potential unknown confounding variables were not considered in our present investigation, such as the changes in estrogen and the number of pregnancies. Fourthly, the indices such as exercise, lifestyle and anthropometric indices are dynamic and changing, and we do not take into account the changes of these indices over the follow-up period. As a result, further multicenter, large-size, prospective studies focusing on imaging indicators and dynamic changes of covariables may strengthen our conclusion.

Conclusion

In summary, our results implied that the four abdominal obesity indicators (WC, LAP, VAI and CVAI) were associated with the increased risk for developing CVD among postmenopausal women. Especially, CVAI exhibited the best performance for predicting incident CVD. Our results suggested that CVAI might be a valuable abdominal obesity indicator for identifying the high risk of CVD incidence in postmenopausal women.

Supplementary Information

Additional file 1: Table S1. Correlations of baseline abdominal obesity indices with incident CVD among postmenopausal women after adjusted using Model 1, 2 and 3. Table S2. The predictive performance of abdominal obesity indices for incident CHD and stroke among postmenopausal women. Table S3. Correlations of baseline CVAI with incident CHD and stroke among postmenopausal women. Figure S1. Kaplan–Meier curves of CHD and stroke by CVAI quartiles.

Abbreviations

WC Waist circumference

WHR Waist–hip ratio

VAI Visceral adiposity index

LAP Lipid accumulation product

CVAI Chinese visceral adiposity index

CVD Cardiovascular disease

ROC Receiver operating characteristic

HR Hazard ratio

AUC Area under the curve

BMI Body mass index

ECG Electrocardiogram

CHD Coronary heart disease

IPAQ International Physical Activity Questionnaire

MET Metabolic equivalent task

DM Diabetic mellitus

SBP Systolic blood pressure

DBP Diastolic blood pressure

TC Total cholesterol

TG Triglyceride

FPG Fasting plasma glucose

HDL-C High-density lipoprotein cholesterol

LDL-C Low-density lipoprotein cholesterol

SD Standard deviations

CI Confidence interval

NRI Net reclassification index

IDI Integrated discrimination improvement

IGF Insulin-like growth factor

VAT Visceral adiposity tissue

SASP Senescence-associated secretory phenotype

CT Computed tomography

DXA Dual-energy x-ray absorptiometry

MRI Magnetic resonance imaging

Acknowledgements

Not applicable.

Author contributions

LL, JP, DZ, TZ and JY drafted, revised the manuscript and contributed to the conception and design of this article. LL, JP and DZ were responsible for the statistical analysis. JY, YZ, ZW and FL contributed to the case collection and database establishment. LL, JP, DZ, CS, SC, DG, TZ and JY interpreted the results. All authors approved the final manuscript.

Funding

This work was supported by the National Key Research and Development Program of China (No. 2021YFF0501403) and the Key Research and Development Plan of Shandong Province (No. 2021SFGC0503).

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Declarations

Ethics approval and consent to participate

The study was approved by the Ethics Review committee of the Shandong Academy of Medical Sciences (Approval Number: 202111120194) and complied with the Declaration of Helsinki. All participants provided written informed consent.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Li Liu, Jie Peng and Dejin Zang contributed equally to this work.
==== Refs
References

1. Virani SS Alonso A Benjamin EJ Bittencourt MS Callaway CW Carson AP Heart disease and stroke statistics-2020 update: a report from the American heart association Circulation 2020 141 9 e139 e596 10.1161/CIR.0000000000000757 31992061
Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics-2020 update: a report from the American heart association. Circulation. 2020;141(9):e139–596.31992061
2. Vogel B Acevedo M Appelman Y Bairey Merz CN Chieffo A Figtree GA The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030 Lancet 2021 397 10292 2385 2438 10.1016/S0140-6736(21)00684-X 34010613
Vogel B, Acevedo M, Appelman Y, Bairey Merz CN, Chieffo A, Figtree GA, et al. The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. Lancet. 2021;397(10292):2385–438.34010613
3. Bairey Merz CN Andersen H Sprague E Burns A Keida M Walsh MN Knowledge, attitudes, and beliefs regarding cardiovascular disease in women: the women’s heart alliance J Am Coll Cardiol 2017 70 2 123 132 10.1016/j.jacc.2017.05.024 28648386
Bairey Merz CN, Andersen H, Sprague E, Burns A, Keida M, Walsh MN, et al. Knowledge, attitudes, and beliefs regarding cardiovascular disease in women: the women’s heart alliance. J Am Coll Cardiol. 2017;70(2):123–32.28648386
4. Cushman M Shay CM Howard VJ Jiménez MC Lewey J McSweeney JC Ten-year differences in women’s awareness related to coronary heart disease: results of the 2019 American heart association national survey: a special report from the American heart association Circulation 2021 143 7 e239 e248 10.1161/CIR.0000000000000907 32954796
Cushman M, Shay CM, Howard VJ, Jiménez MC, Lewey J, McSweeney JC, et al. Ten-year differences in women’s awareness related to coronary heart disease: results of the 2019 American heart association national survey: a special report from the American heart association. Circulation. 2021;143(7):e239–48.32954796
5. Nappi RE Chedraui P Lambrinoudaki I Simoncini T Menopause: a cardiometabolic transition Lancet Diabetes Endocrinol 2022 10 6 442 456 10.1016/S2213-8587(22)00076-6 35525259
Nappi RE, Chedraui P, Lambrinoudaki I, Simoncini T. Menopause: a cardiometabolic transition. Lancet Diabetes Endocrinol. 2022;10(6):442–56.35525259
6. El Khoudary SR Aggarwal B Beckie TM Hodis HN Johnson AE Langer RD Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American heart association Circulation 2020 142 25 e506 e532 10.1161/CIR.0000000000000912 33251828
El Khoudary SR, Aggarwal B, Beckie TM, Hodis HN, Johnson AE, Langer RD, et al. Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American heart association. Circulation. 2020;142(25):e506–32.33251828
7. Colpani V Baena CP Jaspers L van Dijk GM Farajzadegan Z Dhana K Lifestyle factors, cardiovascular disease and all-cause mortality in middle-aged and elderly women: a systematic review and meta-analysis Eur J Epidemiol 2018 33 9 831 845 10.1007/s10654-018-0374-z 29524110
Colpani V, Baena CP, Jaspers L, van Dijk GM, Farajzadegan Z, Dhana K, et al. Lifestyle factors, cardiovascular disease and all-cause mortality in middle-aged and elderly women: a systematic review and meta-analysis. Eur J Epidemiol. 2018;33(9):831–45.29524110
8. Mauvais-Jarvis F Clegg DJ Hevener AL The role of estrogens in control of energy balance and glucose homeostasis Endocr Rev 2013 34 3 309 338 10.1210/er.2012-1055 23460719
Mauvais-Jarvis F, Clegg DJ, Hevener AL. The role of estrogens in control of energy balance and glucose homeostasis. Endocr Rev. 2013;34(3):309–38.23460719
9. Kohrt WM Wierman ME Preventing fat gain by blocking follicle-stimulating hormone N Engl J Med 2017 377 3 293 295 10.1056/NEJMcibr1704542 28723332
Kohrt WM, Wierman ME. Preventing fat gain by blocking follicle-stimulating hormone. N Engl J Med. 2017;377(3):293–5.28723332
10. Chandramouli C Tay WT Bamadhaj NS Tromp J Teng TK Yap J Association of obesity with heart failure outcomes in 11 Asian regions: a cohort study PLoS Med 2019 16 9 e1002916 10.1371/journal.pmed.1002916 31550265
Chandramouli C, Tay WT, Bamadhaj NS, Tromp J, Teng TK, Yap J, et al. Association of obesity with heart failure outcomes in 11 Asian regions: a cohort study. PLoS Med. 2019;16(9): e1002916.31550265
11. Kanaley JA Sames C Swisher L Swick AG Ploutz-Snyder LL Steppan CM Abdominal fat distribution in pre- and postmenopausal women: the impact of physical activity, age, and menopausal status Metabolism 2001 50 8 976 982 10.1053/meta.2001.24931 11474488
Kanaley JA, Sames C, Swisher L, Swick AG, Ploutz-Snyder LL, Steppan CM, et al. Abdominal fat distribution in pre- and postmenopausal women: the impact of physical activity, age, and menopausal status. Metabolism. 2001;50(8):976–82.11474488
12. Toth MJ Tchernof A Sites CK Poehlman ET Menopause-related changes in body fat distribution Ann N Y Acad Sci 2000 904 502 506 10.1111/j.1749-6632.2000.tb06506.x 10865795
Toth MJ, Tchernof A, Sites CK, Poehlman ET. Menopause-related changes in body fat distribution. Ann N Y Acad Sci. 2000;904:502–6.10865795
13. Koenen M Hill MA Cohen P Sowers JR Obesity, adipose tissue and vascular dysfunction Circ Res 2021 128 7 951 968 10.1161/CIRCRESAHA.121.318093 33793327
Koenen M, Hill MA, Cohen P, Sowers JR. Obesity, adipose tissue and vascular dysfunction. Circ Res. 2021;128(7):951–68.33793327
14. Brahimaj A Rivadeneira F Muka T Sijbrands E Franco OH Dehghan A Novel metabolic indices and incident type 2 diabetes among women and men: the Rotterdam study Diabetologia 2019 62 9 1581 1590 10.1007/s00125-019-4921-2 31183505
Brahimaj A, Rivadeneira F, Muka T, Sijbrands E, Franco OH, Dehghan A, et al. Novel metabolic indices and incident type 2 diabetes among women and men: the Rotterdam study. Diabetologia. 2019;62(9):1581–90.31183505
15. Wang Y Zhao X Chen Y Yao Y Zhang Y Wang N Visceral adiposity measures are strongly associated with cardiovascular disease among female participants in Southwest China: a population-based prospective study Front Endocrinol 2022 13 969753 10.3389/fendo.2022.969753
Wang Y, Zhao X, Chen Y, Yao Y, Zhang Y, Wang N, et al. Visceral adiposity measures are strongly associated with cardiovascular disease among female participants in Southwest China: a population-based prospective study. Front Endocrinol. 2022;13: 969753.
16. Huang YC Huang JC Lin CI Chien HH Lin YY Wang CL Comparison of innovative and traditional cardiometabolic indices in estimating atherosclerotic cardiovascular disease risk in adults Diagnostics 2021 11 4 603 10.3390/diagnostics11040603 33800660
Huang YC, Huang JC, Lin CI, Chien HH, Lin YY, Wang CL, et al. Comparison of innovative and traditional cardiometabolic indices in estimating atherosclerotic cardiovascular disease risk in adults. Diagnostics. 2021;11(4):603.33800660
17. He WC Ju K Gao YM Zhang P Zhang YX Jiang Y Spatial inequality, characteristics of internal migration, and pulmonary tuberculosis in China, 2011–2017: a spatial analysis Infect Dis Poverty 2020 9 1 159 10.1186/s40249-020-00778-0 33213525
He WC, Ju K, Gao YM, Zhang P, Zhang YX, Jiang Y, et al. Spatial inequality, characteristics of internal migration, and pulmonary tuberculosis in China, 2011–2017: a spatial analysis. Infect Dis Poverty. 2020;9(1):159.33213525
18. Craig CL Marshall AL Sjöström M Bauman AE Booth ML Ainsworth BE International physical activity questionnaire: 12-country reliability and validity Med Sci Sports Exerc 2003 35 8 1381 1395 10.1249/01.MSS.0000078924.61453.FB 12900694
Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–95.12900694
19. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S17–38.
20. Chobanian AV Bakris GL Black HR Cushman WC Green LA Izzo JL Jr Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure Hypertension 2003 42 6 1206 1252 10.1161/01.HYP.0000107251.49515.c2 14656957
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206–52.14656957
21. Qiao T Luo T Pei H Yimingniyazi B Aili D Aimudula A Association between abdominal obesity indices and risk of cardiovascular events in Chinese populations with type 2 diabetes: a prospective cohort study Cardiovasc Diabetol 2022 21 1 225 10.1186/s12933-022-01670-x 36320060
Qiao T, Luo T, Pei H, Yimingniyazi B, Aili D, Aimudula A, et al. Association between abdominal obesity indices and risk of cardiovascular events in Chinese populations with type 2 diabetes: a prospective cohort study. Cardiovasc Diabetol. 2022;21(1):225.36320060
22. Afshin A Forouzanfar MH Reitsma MB Sur P Estep K Lee A Health effects of overweight and obesity in 195 countries over 25 years N Engl J Med 2017 377 1 13 27 10.1056/NEJMoa1614362 28604169
Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, Lee A, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13–27.28604169
23. Whitlock G Lewington S Sherliker P Clarke R Emberson J Halsey J Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies Lancet 2009 373 9669 1083 1096 10.1016/S0140-6736(09)60318-4 19299006
Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373(9669):1083–96.19299006
24. Silveira EA Kliemann N Noll M Sarrafzadegan N de Oliveira C Visceral obesity and incident cancer and cardiovascular disease: an integrative review of the epidemiological evidence Obes Rev 2021 22 1 e13088 10.1111/obr.13088 32692447
Silveira EA, Kliemann N, Noll M, Sarrafzadegan N, de Oliveira C. Visceral obesity and incident cancer and cardiovascular disease: an integrative review of the epidemiological evidence. Obes Rev. 2021;22(1): e13088.32692447
25. Pischon T Use of obesity biomarkers in cardiovascular epidemiology Dis Mark 2009 26 5–6 247 263 10.1155/2009/757683
Pischon T. Use of obesity biomarkers in cardiovascular epidemiology. Dis Mark. 2009;26(5–6):247–63.
26. Cornier MA Després JP Davis N Grossniklaus DA Klein S Lamarche B Assessing adiposity: a scientific statement from the American heart association Circulation 2011 124 18 1996 2019 10.1161/CIR.0b013e318233bc6a 21947291
Cornier MA, Després JP, Davis N, Grossniklaus DA, Klein S, Lamarche B, et al. Assessing adiposity: a scientific statement from the American heart association. Circulation. 2011;124(18):1996–2019.21947291
27. Yusuf S Hawken S Ounpuu S Bautista L Franzosi MG Commerford P Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case–control study Lancet 2005 366 9497 1640 1649 10.1016/S0140-6736(05)67663-5 16271645
Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case–control study. Lancet. 2005;366(9497):1640–9.16271645
28. Galic S Oakhill JS Steinberg GR Adipose tissue as an endocrine organ Mol Cell Endocrinol 2010 316 2 129 139 10.1016/j.mce.2009.08.018 19723556
Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol. 2010;316(2):129–39.19723556
29. Ko SH Jung Y Energy metabolism changes and dysregulated lipid metabolism in postmenopausal women Nutrients 2021 13 12 4556 10.3390/nu13124556 34960109
Ko SH, Jung Y. Energy metabolism changes and dysregulated lipid metabolism in postmenopausal women. Nutrients. 2021;13(12):4556.34960109
30. Piché ME Tchernof A Després JP Obesity phenotypes, diabetes, and cardiovascular diseases Circ Res 2020 126 11 1477 1500 10.1161/CIRCRESAHA.120.316101 32437302
Piché ME, Tchernof A, Després JP. Obesity phenotypes, diabetes, and cardiovascular diseases. Circ Res. 2020;126(11):1477–500.32437302
31. Powell-Wiley TM Poirier P Burke LE Després JP Gordon-Larsen P Lavie CJ Obesity and cardiovascular disease: a scientific statement from the American heart association Circulation 2021 143 21 e984 e1010 10.1161/CIR.0000000000000973 33882682
Powell-Wiley TM, Poirier P, Burke LE, Després JP, Gordon-Larsen P, Lavie CJ, et al. Obesity and cardiovascular disease: a scientific statement from the American heart association. Circulation. 2021;143(21):e984–1010.33882682
32. Arsenault BJ Lemieux I Després JP Wareham NJ Kastelein JJ Khaw KT The hypertriglyceridemic-waist phenotype and the risk of coronary artery disease: results from the EPIC-Norfolk prospective population study CMAJ 2010 182 13 1427 1432 10.1503/cmaj.091276 20643837
Arsenault BJ, Lemieux I, Després JP, Wareham NJ, Kastelein JJ, Khaw KT, et al. The hypertriglyceridemic-waist phenotype and the risk of coronary artery disease: results from the EPIC-Norfolk prospective population study. CMAJ. 2010;182(13):1427–32.20643837
33. Lemieux I Pascot A Couillard C Lamarche B Tchernof A Alméras N Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men Circulation 2000 102 2 179 184 10.1161/01.CIR.102.2.179 10889128
Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Alméras N, et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men. Circulation. 2000;102(2):179–84.10889128
34. Wu J Gong L Li Q Hu J Zhang S Wang Y A novel visceral adiposity index for prediction of type 2 diabetes and pre-diabetes in Chinese adults: a 5-year prospective study Sci Rep 2017 7 1 13784 10.1038/s41598-017-14251-w 29062099
Wu J, Gong L, Li Q, Hu J, Zhang S, Wang Y, et al. A novel visceral adiposity index for prediction of type 2 diabetes and pre-diabetes in Chinese adults: a 5-year prospective study. Sci Rep. 2017;7(1):13784.29062099
35. Mahoney SA Dey AK Basisty N Herman AB Identification and functional analysis of senescent cells in the cardiovascular system using omics approaches Am J Physiol Heart Circ Physiol 2023 325 5 H1039 H1058 10.1152/ajpheart.00352.2023 37656130
Mahoney SA, Dey AK, Basisty N, Herman AB. Identification and functional analysis of senescent cells in the cardiovascular system using omics approaches. Am J Physiol Heart Circ Physiol. 2023;325(5):H1039–58.37656130
36. Han M Qie R Li Q Liu L Huang S Wu X Chinese visceral adiposity index, a novel indicator of visceral obesity for assessing the risk of incident hypertension in a prospective cohort study Br J Nutr 2021 126 4 612 620 10.1017/S0007114520004298 33143773
Han M, Qie R, Li Q, Liu L, Huang S, Wu X, et al. Chinese visceral adiposity index, a novel indicator of visceral obesity for assessing the risk of incident hypertension in a prospective cohort study. Br J Nutr. 2021;126(4):612–20.33143773
37. Bi H Zhang Y Qin P Wang C Peng X Chen H Association of Chinese visceral adiposity index and its dynamic change with risk of carotid plaque in a large cohort in China J Am Heart Assoc 2022 11 1 e022633 10.1161/JAHA.121.022633 34970911
Bi H, Zhang Y, Qin P, Wang C, Peng X, Chen H, et al. Association of Chinese visceral adiposity index and its dynamic change with risk of carotid plaque in a large cohort in China. J Am Heart Assoc. 2022;11(1): e022633.34970911
38. Xie Y Zhang Y Qin P Ping Z Wang C Peng X The association between Chinese visceral adipose index and coronary heart disease: a cohort study in China Nutr Metab Cardiovasc Dis 2022 32 3 550 559 10.1016/j.numecd.2021.10.020 34961647
Xie Y, Zhang Y, Qin P, Ping Z, Wang C, Peng X, et al. The association between Chinese visceral adipose index and coronary heart disease: a cohort study in China. Nutr Metab Cardiovasc Dis. 2022;32(3):550–9.34961647
39. Zhao Y Zhang J Chen C Qin P Zhang M Shi X Comparison of six surrogate insulin resistance indexes for predicting the risk of incident stroke: the rural Chinese cohort study Diabetes Metab Res Rev 2022 38 7 e3567 10.1002/dmrr.3567 35929532
Zhao Y, Zhang J, Chen C, Qin P, Zhang M, Shi X, et al. Comparison of six surrogate insulin resistance indexes for predicting the risk of incident stroke: the rural Chinese cohort study. Diabetes Metab Res Rev. 2022;38(7): e3567.35929532
40. Zhang Z Zhao L Lu Y Meng X Zhou X Association between Chinese visceral adiposity index and risk of stroke incidence in middle-aged and elderly Chinese population: evidence from a large national cohort study J Transl Med 2023 21 1 518 10.1186/s12967-023-04309-x 37525182
Zhang Z, Zhao L, Lu Y, Meng X, Zhou X. Association between Chinese visceral adiposity index and risk of stroke incidence in middle-aged and elderly Chinese population: evidence from a large national cohort study. J Transl Med. 2023;21(1):518.37525182
41. Shen W Cai L Wang B Wang Y Wang N Lu Y Associations of relative fat mass, a novel adiposity indicator, with non-alcoholic fatty liver disease and cardiovascular disease: data from SPECT-China Diabetes Metab Syndr Obes 2023 16 2377 2387 10.2147/DMSO.S423272 37577042
Shen W, Cai L, Wang B, Wang Y, Wang N, Lu Y. Associations of relative fat mass, a novel adiposity indicator, with non-alcoholic fatty liver disease and cardiovascular disease: data from SPECT-China. Diabetes Metab Syndr Obes. 2023;16:2377–87.37577042
42. Wan H Wang Y Xiang Q Fang S Chen Y Chen C Associations between abdominal obesity indices and diabetic complications: Chinese visceral adiposity index and neck circumference Cardiovasc Diabetol 2020 19 1 118 10.1186/s12933-020-01095-4 32736628
Wan H, Wang Y, Xiang Q, Fang S, Chen Y, Chen C, et al. Associations between abdominal obesity indices and diabetic complications: Chinese visceral adiposity index and neck circumference. Cardiovasc Diabetol. 2020;19(1):118.32736628
43. Dosi R Bhatt N Shah P Patell R Cardiovascular disease and menopause J Clin Diagn Res 2014 8 2 62 64 24701484
Dosi R, Bhatt N, Shah P, Patell R. Cardiovascular disease and menopause. J Clin Diagn Res. 2014;8(2):62–4.24701484
44. Trémollières FA Pouilles JM Cauneille C Ribot C Coronary heart disease risk factors and menopause: a study in 1684 French women Atherosclerosis 1999 142 2 415 423 10.1016/S0021-9150(98)00252-4 10030394
Trémollières FA, Pouilles JM, Cauneille C, Ribot C. Coronary heart disease risk factors and menopause: a study in 1684 French women. Atherosclerosis. 1999;142(2):415–23.10030394
45. Ramirez MF Honigberg M Wang D Parekh JK Bielawski K Courchesne P Protein biomarkers of early menopause and incident cardiovascular disease J Am Heart Assoc 2023 12 16 e028849 10.1161/JAHA.122.028849 37548169
Ramirez MF, Honigberg M, Wang D, Parekh JK, Bielawski K, Courchesne P, et al. Protein biomarkers of early menopause and incident cardiovascular disease. J Am Heart Assoc. 2023;12(16): e028849.37548169
46. Zhu D Chung HF Dobson AJ Pandeya N Giles GG Bruinsma F Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data Lancet Public Health 2019 4 11 e553 e564 10.1016/S2468-2667(19)30155-0 31588031
Zhu D, Chung HF, Dobson AJ, Pandeya N, Giles GG, Bruinsma F, et al. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. Lancet Public Health. 2019;4(11):e553–64.31588031
